
Tarveda Therapeutics Stock
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Sign up today and learn more about Tarveda Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Tarveda Therapeutics Stock
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors. The company's HSP90 targeted drug conjugate platform with lead drug candidate PEN-866 selectively binds in tumors to the activated form of Heat Shock Protein 90 (HSP90) and releases its potent topoisomerase 1 inhibitor payload, SN38 and it also develops a miniature drug conjugate in clinical evaluation for the treatment of patients with somatostatin receptor 2 (SSTR2) expressing neuroendocrine, small cell lung and other solid tumors, enabling companies to extend the lives of patients with hard to treat cancers while minimizing potential toxicities.
Funding History
January 2012 | $2.8M |
---|---|
December 2013 | $21.0M |
March 2014 | $1.0M |
January 2015 | $21.0M |
January 2016 | $38.0M |
February 2017 | $30.0M |
December 2019 | $13.6M |
December 2020 | $15.0M |
September 2021 | $6.0M |
Management
Executive Vice President, Drug Discovery
Mark Bilodeau
Founder
Stephen J. Lippard
Associate Director; Analytical and Formulation Development
Beata Sweryda-Krawiec
President and Chief Executive Officer
Brian Roberts
Board Advisor
Philip Kantoff
Chief Scientific Officer
Mark Bilodeau
Board Member
Guido Magni
Chairman
Drew Fromkin
Board Member
Robert Langer
Board Member
Aymeric Sallin
Board Member
Nilesh Kumar
Board Member
Bibhash Mukhopadhyay
Chief Medical Officer
Jeffrey Bloss
Member Board Of DirectorsMember
Michael Metzger
Board Member
Dennis Ausiello
Board Advisor
Omid Farokhzad
Executive Vice President, Strategy
Sudha Kadiyala
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase